AKT1 and lung carcinoma: Thus, the results demonstrated that torin2 had a strong inhibitory effect on EGFR-TKIs resistant lung cancer cells both in vitro and in vivo. The potential mechanism was associated with reducing the activity of Akt/mTOR signaling.